Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
Add more filters










Publication year range
1.
Klin Khir ; (9): 47-50, 2002 Sep.
Article in Russian | MEDLINE | ID: mdl-12440213

ABSTRACT

Results of treatment of 376 patients, ageing 18-76 yrs, were analyzed to investigate the radioiodine therapy (RITH) efficacy for the thyroid differentiated cancer depending on the term of its conduction after the operation. In patients with the thyroid gland residual tissue (THGRT) only the first course of RITH efficacy was 82.6-96.1%, the THGRT and metastases devitalization in regional lymph nodes and lungs was achieved in 72.7-81.6% of patients. The RITH courses number had constituted 2.5-6.3 at average and median summary activity for one patient--11-33.8 GBq. It was suggested that tendency for the courses number and summary activity enhancement in patients with regional and distant metastases was caused by the tumor tissue mass increase according to elongation the period of time between thyroidectomy and RITH conduction. It is necessary to determine the RITH conduction urgency, basing on the risk factors analysis.


Subject(s)
Postoperative Care , Radiopharmaceuticals/therapeutic use , Serum Albumin, Radio-Iodinated/therapeutic use , Thyroid Neoplasms/drug therapy , Thyroid Neoplasms/surgery , Thyroidectomy/methods , Adolescent , Adult , Aged , Combined Modality Therapy , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Radionuclide Imaging , Thyroid Neoplasms/diagnostic imaging
2.
Klin Khir ; (8): 25-8, 2002 Sep.
Article in Russian | MEDLINE | ID: mdl-12378932

ABSTRACT

Retrospective analysis of efficacy of complex treatment, including surgical intervention, radioiodine therapy (RITH), suppressive hormonotherapy of differentiated forms of the thyroid gland cancer (DFTHGC) was done in 281 patients with positive effect of postoperative distant radiation therapy (PDRTH) application as a component of the treatment. Positive effect of therapy was estimated basing on the dynamic scintigraphy data with 131I and determination of thyroglobulin level in blood serum. The PDRTH conduction does not improve prognosis of the disease, does not lower the tumor metastasizing frequency to regional lymph nodes and remote organs and does not replace RITH. To achieve positive result in 12.8% of patients with PDRTH more than two courses of RITH were performed, enhancing so the total radiation dosage on the organism. To provide protracted nonrecurrent survival of patients with DFTHGC the radical approach is necessary, envisaging performance of thyroidectomy, the timely conduction of RITH with subsequent suppressive therapy using L-thyroxin.


Subject(s)
Thyroid Neoplasms , Thyroxine/therapeutic use , Adult , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Neoplasm Staging , Postoperative Care , Radiopharmaceuticals/therapeutic use , Retrospective Studies , Serum Albumin, Radio-Iodinated/therapeutic use , Thyroid Neoplasms/drug therapy , Thyroid Neoplasms/radiotherapy , Thyroid Neoplasms/surgery , Thyroidectomy/methods
3.
Klin Khir ; (3): 24-7, 2000.
Article in Russian | MEDLINE | ID: mdl-10857308

ABSTRACT

The results of postoperative dynamic examination of 270 patients with differentiated cancer (DC) of thyroid gland (TG) using radionuclide method were analysed. In 74.7% of patients the residual TG tissue was revealed, in 21.8%--the cancer metastases in cervical and mediastinal lymph nodes, in 2.6%--the distant metastases. Inradicalicity of the 1st operation in 14.1% of patients had caused the necessity of the reoperation performance in 43.1% of them. The radioiodine therapy performance after the operation was indicated in 65.5% of patients with DCTG, the distance radiation therapy--in 1.1%. The necessity of performance of postoperative radionuclide monitoring in patients with DCTG was established.


Subject(s)
Postoperative Care , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/surgery , Tomography, Emission-Computed/methods , Adult , Aged , Female , Humans , Male , Middle Aged , Retrospective Studies , Thyroidectomy/methods
4.
Klin Khir ; (11): 39-41, 2000 Nov.
Article in Russian | MEDLINE | ID: mdl-11247457

ABSTRACT

There were examined 200 patients aged from 19 to 77 years with differentiated cancer of the thyroid gland (TG). The combined treatment, which included performance of operation, radioiodine therapy and hormonotherapy, was conducted to all the patients. Total and maximum subtotal TG resection was performed in 90% patients, nonradical operation--in 10%, 23% patients were reoperated. Postoperative monitoring according to chart was done with application of dynamic scintigraphy and determination of the thyroglobuline level in the blood serum. The TG residual tissue (RT) was revealed in 61% patients and in 39%--the cancer metastases in the lymphatic nodes. RT of TG was eliminated in 86.8% patients after the first radioiodine therapy course conduction in middle remedial activity (2.79 +/- 0.11) GBq, the metastases devitalization--in 67.9% in middle remedial activity (4.07 +/- 0.12) GBq.


Subject(s)
Carcinoma, Papillary, Follicular , Thyroid Neoplasms , Adult , Aged , Carcinoma, Papillary, Follicular/drug therapy , Carcinoma, Papillary, Follicular/radiotherapy , Carcinoma, Papillary, Follicular/surgery , Combined Modality Therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Retrospective Studies , Thyroid Neoplasms/drug therapy , Thyroid Neoplasms/radiotherapy , Thyroid Neoplasms/surgery
6.
Klin Khir ; (9-10): 29-32, 1997.
Article in Russian | MEDLINE | ID: mdl-9511322

ABSTRACT

Experience of radionuclide investigation in 493 patients with differentiated cancer of thyroid gland is summarized. The consequences due to incorrect conducting of patients with cancer after the operation were adduced on distinct examples. The program for conducting and observation of patients with thyroid gland cancer after the operation conduction was proposed directed on the early diagnosis of recurrencies and metastases, determination of indications for radioiodine therapy.


Subject(s)
Thyroid Gland/diagnostic imaging , Thyroid Neoplasms/surgery , Adolescent , Adult , Female , Follow-Up Studies , Humans , Iodine Radioisotopes/therapeutic use , Male , Neoplasm Metastasis/diagnostic imaging , Neoplasm Recurrence, Local/diagnostic imaging , Radionuclide Imaging , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/radiotherapy , Thyroidectomy , Time Factors , Treatment Outcome
7.
Lik Sprava ; (7-8): 31-5, 1994.
Article in Russian | MEDLINE | ID: mdl-7900350

ABSTRACT

Combined versus separate exposure of male organism to cesium-137 and chemical agents results in a more pronounced hyperferritinemia in the former case. In female chemists the ferritin level is dependent to a considerable extent on the menstrual cycle showing a tendency for the iron-containing protein level to decrease because of the action of a number of chemical agents. The rise of the level of cancer embryonic antigen is more readily seen in persons with high levels of cesium-137. Concentrations of carbohydrate antigen (CA-125) and mucin-like antigen are appreciably higher in female chemists incorporating cesium-137, and in those within the 30-km radius of the ChNPP. The level of thyroglobulin was raised in the chemists having a background incorporation of cesium, the liquidators of the aftermaths, and particularly in those happened to be in the 30-km zone. Each of the unfavourable factors taken separately (chemical agent or cesium-137) had lesser effect on the degree of elevation of TG content and hormone-forming function of the thyroid gland. An additional information has been obtained concerning the risk groups, which, however, serves as an indirect measure of carcinogenic effect various environmental factors exert on the organism.


Subject(s)
Biomarkers, Tumor/blood , Environmental Pollution/adverse effects , Thyroid Gland/drug effects , Adult , Biomarkers, Tumor/radiation effects , Chemical Industry , Female , Humans , Male , Power Plants , Radioactive Hazard Release , Thyroglobulin/blood , Thyroglobulin/drug effects , Thyroglobulin/radiation effects , Thyroid Gland/physiology , Thyroid Gland/radiation effects , Thyroid Hormones/blood , Thyroid Hormones/radiation effects , Ukraine , Urban Population
8.
Tsitol Genet ; 28(3): 32-7, 1994.
Article in Russian | MEDLINE | ID: mdl-7974780

ABSTRACT

We have summarized the results of cytogenetic studies of peripheral blood lymphocytes conducted in the institutions of Kiev and Kharkov in persons irradiated after the accident of the Chernobyl NPP. The average level of chromosomal aberrations and the appearance of cytogenetic markers characteristic of their irradiation effect was higher in the examinees in comparison with the control. The increase in the number of aberrations in certain Kiev residents as well as the development of lymphogranulomatosis in some liquidators of the accident were detected. The increase in the frequency of chromosomal aberrations in liquidators of the accident was accompanied by the reduction in the level of reparative DNA synthesis of blood lymphocytes. The necessity to expand cytogenetic examination in persons that participated in the liquidation of the accident on the ChNPP and Kiev inhabitants is discussed.


Subject(s)
Chromosome Aberrations , Environmental Exposure/adverse effects , Occupational Exposure/adverse effects , Power Plants , Radioactive Hazard Release , Cells, Cultured , DNA Repair/radiation effects , Hodgkin Disease/blood , Humans , Lymphocytes/metabolism , Lymphocytes/radiation effects , Ukraine
9.
Lik Sprava ; (3-4): 51-6, 1994.
Article in Russian | MEDLINE | ID: mdl-7526556

ABSTRACT

Groups at risk for malignant neoplasia were identified among workmen occupationally exposed to different chemical substances, using immunoradiometric and enzyme immunoassays of tumor-associated antigens. Exposure to the above occupational hazard was found to affect the workmen and cause certain chronic illness accompanied by some increase in concentration of a number of tumoral markers. Increase in tumour antigens suggests indirectly that the chemical substances may have carcinogenic activity. We have every reason to recommend these tests as an additional method for identification of groups at high risk for subsequent development of tumours in the digestive system and reproductive organs of persons occupationally exposed to chemical substances.


Subject(s)
Biomarkers, Tumor/blood , Carcinogens/toxicity , Hazardous Substances/adverse effects , Occupational Exposure/adverse effects , Antigens, Tumor-Associated, Carbohydrate/blood , Antigens, Tumor-Associated, Carbohydrate/drug effects , CA-125 Antigen/blood , CA-125 Antigen/drug effects , CA-19-9 Antigen/blood , CA-19-9 Antigen/drug effects , Carcinoembryonic Antigen/blood , Carcinoembryonic Antigen/drug effects , Female , Ferritins/blood , Ferritins/drug effects , Humans , Male , Occupational Exposure/analysis , Occupational Exposure/statistics & numerical data , Risk Factors , alpha-Fetoproteins/analysis , alpha-Fetoproteins/drug effects
11.
Klin Khir (1962) ; (5): 30-2, 1993.
Article in Russian | MEDLINE | ID: mdl-7933859

ABSTRACT

A radioimmunological analysis of the changes in concentration of tumour markers CA 19-9, REA, beta 2-microglobulin, trypsin and C-peptide was carried out in 53 patients with pancreatic cancer and in 14 patients with cancer of the major duodenal papilla before and 7-10 days after the treatment. A control group was comprised of 116 volunteers. The levels of the tumour markers decreased after the combined use of remote radiotherapy and pancreaticoduodenal resection (PDR). After creation of cholecysto-enteroanastomosis and performance of radiotherapy they remained without changes. Exocrine pancreatic function after remote radiotherapy, especially in combination with PDR, was sharply suppressed.


Subject(s)
Ampulla of Vater , Biomarkers, Tumor/analysis , C-Peptide/analysis , Common Bile Duct Neoplasms/metabolism , Pancreatic Neoplasms/metabolism , Trypsin/analysis , CA-19-9 Antigen/analysis , Combined Modality Therapy , Common Bile Duct Neoplasms/therapy , Humans , Lewis X Antigen/analysis , Pancreatic Neoplasms/therapy , Prohibitins , Radioimmunoassay , Surgical Procedures, Operative/methods , Time Factors , Treatment Outcome , beta 2-Microglobulin/analysis
12.
Vrach Delo ; (8): 66-70, 1991 Aug.
Article in Russian | MEDLINE | ID: mdl-1949740

ABSTRACT

Radioimmunological examination of beta 2-microglobulin in the blood serum of 525 patients revealed that increased protein levels were observed in patients with malignant tumours of the pancreas, duodenal papilla, ovaries, soft tissues, lymphomas. In benign diseases (pancreatitis, ovarian cysts) the beta 2-microglobulin concentration did not significantly exceed the discrimination value. Due to the low sensitivity and specificity this protein has dubious significance as a tumour marker. It is suggested that in some cases of malignant tumours changes of the beta 2-microglobulin level may be related to hepatorenal insufficiency, spread of the disease. These data may provide supplementary information on the prognosis and evolution of the tumour process after combined treatment.


Subject(s)
Neoplasms/blood , beta 2-Microglobulin/analysis , Adult , Child , Humans , Neoplasms/diagnosis , Prognosis , Radioimmunoassay
14.
Med Radiol (Mosk) ; 34(6): 39-42, 1989 Jun.
Article in Russian | MEDLINE | ID: mdl-2739519

ABSTRACT

The paper is concerned with the results of CA-125 radioimmunoassay in 163 patients (584 tests) with benign and malignant ovarian diseases and other small pelvic diseases which were diagnosed before operation as ovarian tumors. CA-125 radioimmunoassay can be used in combination with other methods for investigation of patients with suspected ovarian cancer and for differential diagnosis of malignant ovarian tumors to distinguish them from other malignant tumors of the small pelvis. The total accuracy of the method, its sensitivity and specificity were 94.6%, 96.9 and 93.2%, respectively. CA-125 levels were considerably increased in malignant ovarian tumors irrespective of their histological structure. The investigation of CA-125 indices in the course of disease was indicative of the effectiveness of antitumor therapy.


Subject(s)
Antigens, Tumor-Associated, Carbohydrate/analysis , Ovarian Neoplasms/therapy , Adenocarcinoma/immunology , Adenocarcinoma/therapy , Adult , Combined Modality Therapy , Cystadenocarcinoma/immunology , Cystadenocarcinoma/therapy , Cystadenoma/immunology , Cystadenoma/therapy , Female , Humans , Middle Aged , Ovarian Neoplasms/immunology , Prognosis , Radioimmunoassay
16.
Klin Khir (1962) ; (11): 15-7, 1989.
Article in Russian | MEDLINE | ID: mdl-2625847

ABSTRACT

The CA 19-9 antigen content was studied in 163 patients with pancreatic diseases by radioimmunologic method with the use of commercial test-kits ("Sorin", France). Pancreatitis was diagnosed in 67 patients, pancreatic cancer--in 23, cancer of the major duodenal papilla (MDP)--in 14, malignant neoplasms of the stomach, colon and rectum, liver--in 58. All the results were verified by morphologic studies. The control group included 22 donors. In patients with pancreatic cancer, the considerable increase in the CA 19-9 level was noted when compared with antigen content in the norm and in the other patients examined. The indices of CA 19-9 in pancreatitis don't differ from the normal ones. In MDP cancer and malignant tumours of other location with tumour invasion into the pancreas, the serum CA 19-9 level was increased.


Subject(s)
Antigens, Tumor-Associated, Carbohydrate/analysis , Pancreatic Neoplasms/diagnosis , Biomarkers, Tumor/blood , Diagnosis, Differential , Humans , Male , Middle Aged , Pancreatic Neoplasms/blood , Pancreatic Neoplasms/immunology , Pancreatitis/blood , Pancreatitis/diagnosis , Pancreatitis/immunology , Radioimmunoassay
17.
Med Radiol (Mosk) ; 32(10): 32-6, 1987 Oct.
Article in Russian | MEDLINE | ID: mdl-3657434

ABSTRACT

The levels of tumor markers--CEA, ferritin and prolactin (the hormone of the anterior pituitary gland) were studied in the blood serum of 178 breast cancer patients in the menopause during combined therapy using a radioimmunoassay. This combination was shown to be informative for assessment of prognosis of disease and efficacy of antitumor therapy which was confirmed by clinical and x-ray findings and observation of a tumor process in breast cancer patients over a 5-year period.


Subject(s)
Biomarkers, Tumor/blood , Breast Neoplasms/therapy , Carcinoembryonic Antigen/blood , Ferritins/blood , Prolactin/blood , Breast Neoplasms/blood , Female , Humans , Prognosis , Radioimmunoassay
SELECTION OF CITATIONS
SEARCH DETAIL
...